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VI. Executive Summary 
A fundamental issue in healthcare is the development of cost-effective and reliable diagnostic assays.  
While still a relatively new field, paper-based analytical devices are emerging as inexpensive and portable 
methods of providing healthcare professionals with real-time diagnostic information. Furthermore, these 
devices can often be used at the point of care, thus eliminating the need for a myriad of time-consuming 
laboratory techniques. 
While the original goal of this project was to develop a paper-based lateral flow immunoassay capable 
of colorimetric quantitation, the device design was altered over the course of the past year. Upon testing, 
the originally proposed lateral flow assay lacked adequate sensitivity and reliability. Therefore, a novel 
three-dimensional paper-based analytical device was developed. This new device design utilizes enzymatic 
amplification to break down a biomatrix, ultimately producing a chronometric readout. This unique 
biomatrix can detect <1 femtomole (10-15) of analyte, with degradation time being directly correlated to 
analyte concentration. Thus far, device storage conditions, viable pH ranges, and viable temperature ranges 
have been determined. While further refinement is still needed, these diagnostic devices have the potential 
to revolutionize point-of-care assays through the quantification of analytes in both field and clinical settings.
 
  
 
   
 
 
 
 
   
 
  
 
         
     
         
 
 
VII. Major Accomplishments
(1) Device Storage: Device longevity was examined through storage at room temperature over a
three-month period, with functionality being tested monthly.  The biomatrix displayed no 
appreciable indication of auto-degradation, while applied pro-enzymes displayed slightly 
reduced functionality over time.  This data indicates assay viability in field settings where
specialized storage conditions (ie. refrigeration) may be unavailable.
(2) pH: Device functionality was tested using a series of buffers with a wide range of pH values.  
The device biomatrix displayed functionality at pH values 1-9.  This indicates device viability 
with analytes of varying pH requirements.
(3) Temperature: Device stability at varying temperatures was also tested. Our findings indicate
that standard device functionality remains consistent between 17-29°C (with 40-50% humidity).  
This allows for assay viability in a wide range of ambient environments, even without
specialized storage equipment.
